SEC Form 4 · accession 0001104659-16-133523
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy M. Block
Director
Period of report
Jul 19, 2016
Accepted (ET)
Jul 20, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $1.04 | Jul 19, 2016 | A | 65,000 | A | — | Jul 19, 2026 | Common Stock | 65,000 | 169,688 | D |
Explanation of responses
- F132,500 stock options vest immediately and 32,500 vest on July 19, 2017.